University of Virginia School of Medicine researchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs.
Community-led intervention curbs childhood obesity and boosts quality of life
The RESPOND trial adapted to COVID-19 disruptions by shifting to a cluster-parallel randomized design, enabling analysis despite the pandemic’s impact on school and community participation
November 12, 2024